Advanced Biomed Inc.
ADVB
$0.42
$0.001.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -14.90% | 97.44% | 18.62% | -39.01% | 24.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.75% | 72.08% | 2.32% | -19.28% | 18.13% |
| Operating Income | -0.75% | -72.08% | -2.32% | 19.28% | -18.13% |
| Income Before Tax | -45.67% | 13.32% | -31.03% | -524.85% | 65.56% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -45.67% | 13.32% | -31.03% | -524.85% | 65.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.67% | 13.32% | -31.03% | -524.85% | 65.56% |
| EBIT | -0.75% | -72.08% | -2.32% | 19.28% | -18.13% |
| EBITDA | -13.91% | -108.48% | -3.35% | 26.16% | -19.07% |
| EPS Basic | -34.59% | 20.00% | -28.03% | -521.92% | 65.54% |
| Normalized Basic EPS | -34.94% | 19.76% | -27.88% | -531.11% | 65.56% |
| EPS Diluted | -34.59% | 20.00% | -28.03% | -521.92% | 65.54% |
| Normalized Diluted EPS | -34.94% | 19.76% | -27.88% | -531.11% | 65.56% |
| Average Basic Shares Outstanding | 8.20% | 8.17% | 2.40% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 8.20% | 8.17% | 2.40% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |